Table 2.
Log-linear models | 95% CI () | df | G2 | p | AIC | DIC | |||
---|---|---|---|---|---|---|---|---|---|
Model 1: DO*EPF, LABO*EPF, EPF*place |
154 |
370 |
270 |
469 |
100 |
145,75 |
0,00 |
−54,25 |
−142,31 |
Model 2: DO*EPF, LABO*EPF, EPF*region |
154 |
370 |
270 |
469 |
100 |
133,74 |
0,01 |
−66,26 |
−154,32 |
Model 3: DO*EPF, LABO*EPF, EPF*année, Labo*année |
154 |
370 |
270 |
469 |
95 |
141,78 |
0,00 |
−48,22 |
−131,88 |
Model 4: DO*EPF, LABO*EPF, EPF*place, EPF*region, DO*region |
147 |
363 |
266 |
460 |
97 |
125,12 |
0,03 |
−68,88 |
−154,30 |
Model 5: DO*EPF, LABO*EPF, EPF*place, EPF*year |
131 |
347 |
260 |
434 |
94 |
132,81 |
0,00 |
−55,19 |
−137,96 |
Model 6: DO*EPF, LABO*EPF, EPF*region, DO*region, EPF*year |
141 |
357 |
261 |
452 |
96 |
121,31 |
0,02 |
−64,69 |
−146,59 |
Model 7: DO*EPF, LABO*EPF, DO*place, EPF*place, DO*region, Labo*region, EPF*region, EPF*year |
171 |
387 |
271 |
503 |
93 |
112,72 |
0,07 |
−73,28 |
−155,17 |
Model 8: DO*EPF, LABO*EPF, DO*place, EPF*place, DO*region, Labo*region, EPF*region | 171 | 387 | 271 | 503 | 96 | 112,48 | 0,05 | −73,52 | −158,06 |
DO: Mandatory HIV case reporting; EPF: ANRS French Perinatal Cohort; Labo: Laboratory surveillance of HIV testing activity.
: Estimate of the number of diagnoses not reported to any source; : Estimate of the number of diagnoses; 95% CI: 95% confidence interval for ; df: number of degrees of freedom; G2: deviance statistic; p: p-value of the deviance goodness-of-fit test; AIC: Akaike Information Criterion; DIC: Draper Information Criterion
Place: place of birth; region: region of diagnosis; year: year of diagnosis.